Canada markets close in 5 hours 42 minutes
  • S&P/TSX

    20,550.31
    -78.61 (-0.38%)
     
  • S&P 500

    4,098.45
    -12.63 (-0.31%)
     
  • DOW

    33,754.92
    -136.10 (-0.40%)
     
  • CAD/USD

    0.7426
    -0.0011 (-0.15%)
     
  • CRUDE OIL

    75.77
    +1.66 (+2.24%)
     
  • BTC-CAD

    30,915.83
    -27.26 (-0.09%)
     
  • CMC Crypto 200

    527.62
    +1.67 (+0.32%)
     
  • GOLD FUTURES

    1,881.60
    +2.10 (+0.11%)
     
  • RUSSELL 2000

    1,946.12
    -11.59 (-0.59%)
     
  • 10-Yr Bond

    3.6440
    +0.0100 (+0.28%)
     
  • NASDAQ

    11,867.10
    -20.35 (-0.17%)
     
  • VOLATILITY

    19.70
    +0.27 (+1.39%)
     
  • FTSE

    7,856.16
    +19.45 (+0.25%)
     
  • NIKKEI 225

    27,685.47
    -8.18 (-0.03%)
     
  • CAD/EUR

    0.6956
    +0.0025 (+0.36%)
     

Stocks in play: Microbix Biosystems Inc.

Announces that, on behalf of Santina Castriciano of Copan Italia S.p.A. and in collaboration with Victorian Cytology Service of the Australian Centre for the Prevention of Cervical Cancer (VCS Pathology), it will present results of novel methods to support diagnostic accuracy and whole-process workflow validation of cervical cancer screening tests on self-collected patient specimens. The poster presentation will be made at the 12th European Meeting on Molecular Diagnostics taking place in Noordwijk, Netherlands from October 12 to 14. Microbix Biosystems Inc. shares T.MBX are trading down $0.01 at $0.50.

Read: